Skip to main content
Top
Published in: Rheumatology International 1/2020

01-01-2020 | Vasculitis | Cohort Studies

Familial Mediterranean fever is associated with a wide spectrum of inflammatory disorders: results from a large cohort study

Authors: Nuh Atas, Berkan Armagan, Erdal Bodakci, Hasan Satis, Alper Sari, Nazife Sule Yasar Bilge, Reyhan Bilici Salman, Gozde Kubra Yardımcı, Hakan Babaoglu, Aslihan Avanoglu Guler, Hazan Karadeniz, Levent Kilic, Mehmet Akif Ozturk, Berna Goker, Seminur Haznedaroglu, Umut Kalyoncu, Timucin Kasifoglu, Abdurrahman Tufan

Published in: Rheumatology International | Issue 1/2020

Login to get access

Abstract

Familial Mediterranean fever (FMF) is characterized by recurrent short-lived/self-limiting inflammatory attacks. Besides these, a substantial number of patients with FMF present with a variety of other inflammatory diseases; however, this issue has not been systematically studied previously. Hence, we aimed to investigate the frequency of inflammatory comorbid diseases in a large FMF cohort. All patients were recruited from “FMF in Central Anatolia (FiCA) Cohort”, comprising 971 (mean age 35.3 ± 12 years, 61.5% female) adult subjects. All patients fulfilled Tel Hashomer criteria. Demographic data, FMF disease characteristics, MEFV gene mutations, and comorbid inflammatory diseases were meticulously questioned, and laboratory features and genotype data were retrieved from hospital records. There were comorbid inflammatory diseases in 205 (21.1%) patients. The most common inflammatory disease was spondyloarthritis (12.9%). Other remarkable inflammatory disorders were psoriasis, immunoglobulin A vasculitis/Henoch–Schönlein purpura, Behçet’s disease and inflammatory bowel diseases. Cryptogenic organizing pneumonia is a newly defined entity in our cohort which is seemed to be associated with FMF (0.3%). Number of patients with persistent inflammation was higher in those with comorbid diseases (p < 0.001). Our results suggest that FMF is commonly associated with other inflammatory diseases. Therefore, clinicians should be cautious about comorbid inflammatory diseases in FMF patients, particularly in those with persistent inflammation. Identification of pathogenic pathways linking FMF to these diseases warrants further investigations.
Literature
5.
go back to reference Gafni J, Ravid M, Sohar E (1968) The role of amyloidosis in familial Mediterranean fever. A population study. Isr J Med Sci 4(5):995–999PubMed Gafni J, Ravid M, Sohar E (1968) The role of amyloidosis in familial Mediterranean fever. A population study. Isr J Med Sci 4(5):995–999PubMed
7.
go back to reference Ozen S (2009) Mutations/polymorphisms in a monogenetic autoinflammatory disease may be susceptibility markers for certain rheumatic diseases: lessons from the bedside for the benchside. Clin Exp Rheumatol 27(2 Suppl 53):S29–S31PubMed Ozen S (2009) Mutations/polymorphisms in a monogenetic autoinflammatory disease may be susceptibility markers for certain rheumatic diseases: lessons from the bedside for the benchside. Clin Exp Rheumatol 27(2 Suppl 53):S29–S31PubMed
10.
go back to reference Cattan D (2005) MEFV mutation carriers and diseases other than familial Mediterranean fever: proved and non-proved associations; putative biological advantage. Curr Drug Targets Inflamm Allergy 4(1):105–112CrossRef Cattan D (2005) MEFV mutation carriers and diseases other than familial Mediterranean fever: proved and non-proved associations; putative biological advantage. Curr Drug Targets Inflamm Allergy 4(1):105–112CrossRef
11.
go back to reference Maras Y, Akdogan A, Kisacik B, Kilic L, Yilmaz E, Tufan A et al (2014) MEFV mutation frequency and effect on disease severity in ankylosing spondylitis. Turk J Med Sci 44(2):203–207CrossRef Maras Y, Akdogan A, Kisacik B, Kilic L, Yilmaz E, Tufan A et al (2014) MEFV mutation frequency and effect on disease severity in ankylosing spondylitis. Turk J Med Sci 44(2):203–207CrossRef
14.
go back to reference Tufan A, Babaoglu MO, Akdogan A, Yasar U, Calguneri M, Kalyoncu U et al (2007) Association of drug transporter gene ABCB1 (MDR1) 3435C to T polymorphism with colchicine response in familial Mediterranean fever. J Rheumatol 34(7):1540–1544PubMed Tufan A, Babaoglu MO, Akdogan A, Yasar U, Calguneri M, Kalyoncu U et al (2007) Association of drug transporter gene ABCB1 (MDR1) 3435C to T polymorphism with colchicine response in familial Mediterranean fever. J Rheumatol 34(7):1540–1544PubMed
18.
go back to reference Aksentijevich I, Putnam CD, Remmers EF, Mueller JL, Le J, Kolodner RD et al (2007) The clinical continuum of cryopyrinopathies: novel CIAS1 mutations in North American patients and a new cryopyrin model. Arthritis Rheumatol 56(4):1273–1285. https://doi.org/10.1002/art.22491 CrossRef Aksentijevich I, Putnam CD, Remmers EF, Mueller JL, Le J, Kolodner RD et al (2007) The clinical continuum of cryopyrinopathies: novel CIAS1 mutations in North American patients and a new cryopyrin model. Arthritis Rheumatol 56(4):1273–1285. https://​doi.​org/​10.​1002/​art.​22491 CrossRef
21.
go back to reference Garcia-Gonzalez A, Weisman MH (1992) The arthritis of familial Mediterranean fever. Semin Arthritis Rheum 22(3):139–150CrossRef Garcia-Gonzalez A, Weisman MH (1992) The arthritis of familial Mediterranean fever. Semin Arthritis Rheum 22(3):139–150CrossRef
22.
go back to reference Majeed HA, Rawashdeh M (1997) The clinical patterns of arthritis in children with familial Mediterranean fever. QJM 90(1):37–43CrossRef Majeed HA, Rawashdeh M (1997) The clinical patterns of arthritis in children with familial Mediterranean fever. QJM 90(1):37–43CrossRef
23.
go back to reference Kaushansky K, Finerman GA, Schwabe AD (1981) Chronic destructive arthritis in familial Mediterranean fever: the predominance of hip involvement and its management. Clin Orthop Relat Res 155:156–161 Kaushansky K, Finerman GA, Schwabe AD (1981) Chronic destructive arthritis in familial Mediterranean fever: the predominance of hip involvement and its management. Clin Orthop Relat Res 155:156–161
24.
go back to reference Tunca M, Akar S, Onen F, Ozdogan H, Kasapcopur O, Yalcinkaya F et al (2005) Familial Mediterranean fever (FMF) in Turkey: results of a nationwide multicenter study. Medicine (Baltimore) 84(1):1–11CrossRef Tunca M, Akar S, Onen F, Ozdogan H, Kasapcopur O, Yalcinkaya F et al (2005) Familial Mediterranean fever (FMF) in Turkey: results of a nationwide multicenter study. Medicine (Baltimore) 84(1):1–11CrossRef
27.
go back to reference Onen F, Akar S, Birlik M, Sari I, Khan MA, Gurler O et al (2008) Prevalence of ankylosing spondylitis and related spondyloarthritides in an urban area of Izmir, Turkey. J Rheumatol 35(2):305–309PubMed Onen F, Akar S, Birlik M, Sari I, Khan MA, Gurler O et al (2008) Prevalence of ankylosing spondylitis and related spondyloarthritides in an urban area of Izmir, Turkey. J Rheumatol 35(2):305–309PubMed
30.
go back to reference Ozdogan H, Arisoy N, Kasapcapur O, Sever L, Caliskan S, Tuzuner N et al (1997) Vasculitis in familial Mediterranean fever. J Rheumatol 24(2):323–327PubMed Ozdogan H, Arisoy N, Kasapcapur O, Sever L, Caliskan S, Tuzuner N et al (1997) Vasculitis in familial Mediterranean fever. J Rheumatol 24(2):323–327PubMed
33.
go back to reference Ben-Chetrit E, Cohen R, Chajek-Shaul T (2002) Familial mediterranean fever and Behcet’s disease—are they associated? J Rheumatol 29(3):530–534PubMed Ben-Chetrit E, Cohen R, Chajek-Shaul T (2002) Familial mediterranean fever and Behcet’s disease—are they associated? J Rheumatol 29(3):530–534PubMed
34.
go back to reference Schwartz T, Langevitz P, Zemer D, Gazit E, Pras M, Livneh A (2000) Behcet’s disease in Familial Mediterranean fever: characterization of the association between the two diseases. Semin Arthritis Rheum 29(5):286–295CrossRef Schwartz T, Langevitz P, Zemer D, Gazit E, Pras M, Livneh A (2000) Behcet’s disease in Familial Mediterranean fever: characterization of the association between the two diseases. Semin Arthritis Rheum 29(5):286–295CrossRef
35.
go back to reference Azizlerli G, Kose AA, Sarica R, Gul A, Tutkun IT, Kulac M et al (2003) Prevalence of Behcet’s disease in Istanbul, Turkey. Int J Dermatol 42(10):803–806CrossRef Azizlerli G, Kose AA, Sarica R, Gul A, Tutkun IT, Kulac M et al (2003) Prevalence of Behcet’s disease in Istanbul, Turkey. Int J Dermatol 42(10):803–806CrossRef
36.
go back to reference Ozen S, Karaaslan Y, Ozdemir O, Saatci U, Bakkaloglu A, Koroglu E et al (1998) Prevalence of juvenile chronic arthritis and familial Mediterranean fever in Turkey: a field study. J Rheumatol 25(12):2445–2449PubMed Ozen S, Karaaslan Y, Ozdemir O, Saatci U, Bakkaloglu A, Koroglu E et al (1998) Prevalence of juvenile chronic arthritis and familial Mediterranean fever in Turkey: a field study. J Rheumatol 25(12):2445–2449PubMed
42.
go back to reference Lichtenberger GS, Flavell RA, Alexopoulou L (2004) Innate immunity and apoptosis in IBD. Inflamm Bowel Dis 10(Suppl 1):S58–S62CrossRef Lichtenberger GS, Flavell RA, Alexopoulou L (2004) Innate immunity and apoptosis in IBD. Inflamm Bowel Dis 10(Suppl 1):S58–S62CrossRef
Metadata
Title
Familial Mediterranean fever is associated with a wide spectrum of inflammatory disorders: results from a large cohort study
Authors
Nuh Atas
Berkan Armagan
Erdal Bodakci
Hasan Satis
Alper Sari
Nazife Sule Yasar Bilge
Reyhan Bilici Salman
Gozde Kubra Yardımcı
Hakan Babaoglu
Aslihan Avanoglu Guler
Hazan Karadeniz
Levent Kilic
Mehmet Akif Ozturk
Berna Goker
Seminur Haznedaroglu
Umut Kalyoncu
Timucin Kasifoglu
Abdurrahman Tufan
Publication date
01-01-2020
Publisher
Springer Berlin Heidelberg
Published in
Rheumatology International / Issue 1/2020
Print ISSN: 0172-8172
Electronic ISSN: 1437-160X
DOI
https://doi.org/10.1007/s00296-019-04412-7

Other articles of this Issue 1/2020

Rheumatology International 1/2020 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.